Live Breaking News & Updates on Citalopram

Stay informed with the latest breaking news from Citalopram on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Citalopram and stay connected to the pulse of your community

Empagliflozin Shows Promise As An Adjunct To Selective Serotonin Reuptake Inhibitors In Reducing Symptom Severity In Major Depressive Disorder

1. Combination therapy of empagliflozin and citalopram reduced symptom severity in patients with major depressive disorder. 2. This average reduction in symptom severity was statistically significant over time in comparison to the reduction of symptoms seen in the placebo-citalopram group. Evidence Rating Level: 1 (Excellent) Antidepressants like selective serotonin reuptake inhibitors (SSRIs) are presently first-line

Minute-medicine-inc , Rating-level , Hamilton-depression-rating-scale , Citalopram , Depression , Empagliflozin , Mdd , Sglt2 , Psychiatry , Wellness ,

Safety Warning for Citalopram Did Not Improve Outcomes for Vets

Instead of reducing risk, the citalopram dose reduction suggested by the FDA was associated with an increase in hospitalizations.

United-states , American , American-journal , Thomas-rector , American-journal-of-psychiatry , Citalopram , Epression , Da , Eterans ,